Management of an anaphylactoid reaction to methotrexate with a stepwise graded challenge

Pediatric Allergy and Immunology

Volumn 14, Issue 5, 2003, Pages 409-411

  MacGinnitie, Andrew J ^a   Walensky, Loren D ^a,b   Turvey, Stuart E ^a   Orange, Jordan S ^a   Bonilla, Francisco A ^a   Silverman, Lewis B ^a,b   Oettgen, Hans ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hypersensitivity; Leukemia; Methotrexate; Skin tests

Indexed keywords

ANTIALLERGIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; ANTIPRURITIC AGENT; DEXAMETHASONE; DIPHENHYDRAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; METHOTREXATE; RANITIDINE; THIOTEPA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ANAPHYLAXIS; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; DESENSITIZATION; DOSE RESPONSE; DRUG COMBINATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; HUMAN; IATROGENIC DISEASE; MALE; METHODOLOGY; PRICK TEST; PRIORITY JOURNAL; PRURITUS; SKIN TEST; TREATMENT OUTCOME; URTICARIA;

ADOLESCENT; ANAPHYLAXIS; ANTI-ALLERGIC AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIPRURITICS; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; HISTAMINE H2 ANTAGONISTS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; PRURITUS; RANITIDINE; SKIN TESTS; URTICARIA;

EID: 0242416147     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2003.00073.x     Document Type: Article

References (8)

1. SILVERMAN LB, DECLERCK L, GELBER RD, et al. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-95). Leukemia 2000; 14: 2247-56.
2. SILVERMAN LB, GELBER RD, DALTON VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 2001; 97: 1211-8.
3. GUTIN PH, LEVI JA, WIERNIK PH, WALKER MD. Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study. Cancer Treat Rep 1977; 61: 885-7.
4. NACLEERIO R, MIZRAHI EA, ADKINSON NF JR. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 1983; 71: 294-301.
5. ALKINS SA, BYRD JC, MORGAN SK, WARD FT, WEISS RB. Anaphylactoid reactions to methotrexate. Cancer 1996; 77: 2123-6.
6. DEVECIOGLU O, BINER B, KARABOCUOGLU M, UNUVAR A, AGAOGLU L. Systemic near-fatal anaphylactic reaction after intrathecal methotrexate administration. Med Pediatr Oncol 2000; 34: 151-2.
7. VEGA A, CABANAS R, CONTRERAS J, et al. Anaphylaxis to methotrexate: a possible IgE-mediated mechanism. J Allergy Clin Immunol 1994; 94: 268-70.
8. POSTOVSKY S, ELHASID R, BEN-BARAK A, LEVIN K, BEN ARUSH MW. Allergic reaction to high-dose methotrexate. Med Pediatr Oncol 2000; 35: 131-2.